La Jolla Pharmaceutical Company (LJPC)
La Jolla Pharmaceutical Company (LJPC) Company Bio
La Jolla Pharmaceutical is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for the treatment of serious bacterial infections and rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy. The company was founded in 1989 and is based in San Diego, California.
LJPC Stock Chart More Charts
LJPC Price/Volume Stats
| Current price | $6.30 |
| Prev. close | $6.25 |
| Day low | $5.90 |
| Day high | $6.33 |
| 50-day MA | $11.86 |
| 200-day MA | $22.86 |
| 52-week high | $41.36 |
| 52-week low | $5.01 |
| Volume | 965,700 |
| Avg. volume | 2,348,008 |
| Dividend yield | N/A |
| Market Cap | 165.27M |
LJPC Returns
| 1-mo | -37.62% |
| 3-mo | -61.01% |
| 6-mo | -80.85% |
| 1-year | -79.83% |
| 3-year | -61.63% |
| 5-year | -28.41% |
| YTD | -33.19% |
| 2018 | -70.70% |
| 2017 | 83.57% |
| 2016 | -35.07% |
| 2015 | 46.34% |
| 2014 | 138.06% |
Loading social stream, please wait...